Clinical Trials on Persistent Hyperplastic Primary Vitreous

Total 1023 results

Yune Zhao

Unknown

Congenital Cataract With Persistent Fetal Vasculature

Congenital Cataract | Persistent Fetal Vasculature

China
Universität des Saarlandes

Completed

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Benign Prostatic Hyperplasia | Primary Prostate Urothelial Cancer

Germany
VA Office of Research and Development

Completed

Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS

Benign Prostatic Hyperplasia | Lower Urinary Track Symptoms

United States
St. Joseph's Healthcare Hamilton
Ontario Ministry of Health and Long Term Care

Completed

PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (PVP)

Benign Prostatic Hyperplasia

Canada
GlaxoSmithKline

Completed

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Benign Prostatic Hyperplasia
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Ejaculation Preservation After Laser Enucleation Prostate (EPALEP)

Prostate Hyperplasia

France
ThermaRx, Inc.

Completed

A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy

Urinary Retention | Benign Prostatic Hyperplasia (BPH) | Urinary Hesitancy Intermittent

United States
The Third Affiliated hospital of Zhejiang Chinese...

Not yet recruiting

Benigh Prosatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
Light Sciences Oncology
Mundipharma Research Limited

Completed

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Health Ever Bio-Tech Co., Ltd.

Completed

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
Samsung Medical Center

Completed

Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Urology of Virginia
GlaxoSmithKline

Unknown

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Clinique Saint-Hilaire

Completed

Thuflep/SOLEP : Initial Experience and Results of Prostate Laser Enucleation With Thulium-fiber Laser (TFL)

Prostate Hyperplasia

France
Adana City Training and Research Hospital

Completed

Inflammatory Markers: HOLEP Versus TURP

Prostate Hyperplasia

Turkey
Kafrelsheikh University

Completed

Prostatic Resection Cavity Stone Post Transurethral Resection of the Prostate (TURP). A Rare Case Scenario (prostatic)

Prostate Hyperplasia

Egypt
Centre hospitalier de l'Université de Montréal...
PROCEPT BioRobotics

Recruiting

AQUABEAM® Robotic System and Ultrasound Accessories (AQUA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
University of Rome Tor Vergata

Recruiting

Focal Laser Ablation for Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Italy
Dominik Abt

Recruiting

Database for the Assessment of Efficacy and Safety of BPH Treatment (KSSG-BPH-REG)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Switzerland
University of California, San Francisco
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Deprescribing Tamsulosin in Older Men (PERSONAL)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Health Ever Bio-Tech Co., Ltd.

Completed

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-TWN-c)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
Seoul National University Hospital
Astellas Pharma Korea, Inc.; Medical Research Collaborating Center, Seoul,...

Unknown

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients (ABSOLUTE)

Benign Prostate Hyperplasia

Korea, Republic of
Light Sciences Oncology

Completed

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Light Sciences Oncology

Completed

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

New Zealand, Australia
Samsung Medical Center

Completed

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Assiut University

Not yet recruiting

Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement

Benign Prostatic Hyperplasia
NeoTract, Inc.

Not yet recruiting

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up (RELIEF)

Benign Prostatic Hyperplasia
Assiut University

Not yet recruiting

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Benign Prostatic Hyperplasia

China
Jewish General Hospital

Not yet recruiting

Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study

Benign Prostatic Hyperplasia
Zenflow, Inc.

Recruiting

The Zenflow Spring System EU Safety and Performance Study (ZEST EU)

Benign Prostatic Hyperplasia

Australia, New Zealand
REMD Medical Technology
RenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaborators

Completed

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

China
Bioaraba Health Research Institute

Completed

Effectiveness of Smartconsent in Improving Understanding of Informed Consent (SMARTCONSENT)

Benign Prostatic Hyperplasia

Spain
Helwan University

Completed

Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy

Benign Prostatic Hyperplasia

Egypt
Merit Medical Systems, Inc.

Terminated

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

Benign Prostatic Hyperplasia

United States
University Hospital Southampton NHS Foundation...
BTG International Inc.

Unknown

Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement

Benign Prostatic Hyperplasia

United Kingdom
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Botulinum Toxin Injection for the Management of BPH (MIST2)

Benign Prostatic Hyperplasia

United States
Kafrelsheikh University

Unknown

Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Egypt
James B. Spies, MD

Completed

Prostate Embolization for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Group of Research in Minimally Invasive Techniques
Universidad de Zaragoza; Hospital Clínico Universitario Lozano Blesa

Withdrawn

Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.

Benign Prostatic Hyperplasia

Spain
Laboratoires Bouchara-Recordati
ClinSearch

Completed

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH (UROEVAL)

Benign Prostatic Hyperplasia

France
Jena University Hospital
Boston Scientific Corporation

Completed

Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia (EmboProstate)

Benign Prostatic Hyperplasia

Germany
Mansoura University

Completed

GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT

Benign Prostatic Hyperplasia

Egypt
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Merck Sharp & Dohme LLC

Terminated

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Benign Prostatic Hyperplasia
Yuyu Pharma, Inc.

Completed

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

AVODART(Dutasteride) Post-marketing Surveillance(PMS) (AVO PMS)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

Korea, Republic of

Clinical Trials on Persistent Hyperplastic Primary Vitreous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations